Diagnosis of gastric cancer by serum proteomic fingerprinting

Terence C W Poon ¹, Joseph J Y Sung , Shuk M Chow

⁰Institute of Digestive Diseases of the Chinese University of Hong Kong, Hong Kong, Special Administrative Region, The People's Republic of China.

Gastroenterology +

|

May 16, 2006

View abstract on PubMed

Summary

Researchers identified a unique serum proteomic fingerprint for gastric cancer detection. This novel biomarker signature shows promise for noninvasive diagnosis, improving early detection rates.

Area Of Science

Proteomics
Biomarker Discovery
Cancer Diagnostics

Background

Accurate serum biomarkers for gastric cancer are currently lacking.
Early and noninvasive detection methods are crucial for improving patient outcomes.

Purpose Of The Study

To identify potential diagnostic serum markers for gastric cancer.
To develop and validate a diagnostic model using surface-enhanced laser desorption/ionization (SELDI) ProteinChip technology.

Main Methods

Serum samples from gastric cancer patients and controls were analyzed using SELDI ProteinChip arrays (IMAC30 and CM10).
A three-phase study involved marker discovery, diagnostic model development, and independent validation.
Proteomic features with significant peak intensity differences were identified and verified for tumor-specific expression.

Main Results

31 proteomic features showed significantly higher peak intensities in gastric cancer patients.
Six tumor-specific proteomic features were identified, and a diagnostic index was developed using a linear regression model.
The diagnostic index achieved an area under the receiver operating characteristic curve of 0.92, with 83% sensitivity at 95% specificity in the validation set.

Conclusions

A unique serum proteomic fingerprint indicative of gastric cancer was identified.
This proteomic signature holds potential for the noninvasive diagnosis of gastric cancer.
Further research may lead to improved diagnostic tools for gastric cancer.

Related Concept Videos